DaVita Inc
DVA141.510USD
+1.009+0.72%
Fechamento 04/29, 16:00（ET）Cotações atrasadas em 15 min
11.40BValor de mercado
12.17P/L TTM
Mais detalhes de DaVita Inc Empresa
DaVita Inc. is a healthcare provider focused on transforming care delivery to improve the quality of life for patients globally. The Company is a provider of kidney care services in the United States. Its United States dialysis (U.S. dialysis) and related lab services business treats patients with chronic kidney failure and end-stage kidney disease (ESKD). The Company’s robust platform delivers kidney care services and includes established nephrology and payor relationships. The Company’s international operations provide dialysis and administrative services to a total of outpatient dialysis centers. The Company’s U.S. integrated kidney care (IKC) business provides integrated care and disease management services to patients in risk-based integrated care arrangements and to additional patients in other integrated care arrangements across the United States. It also maintains a few other ancillary services and investments outside its U.S. dialysis, U.S. IKC, or international operations.
Informações da empresa
Código da empresaDVA
Nome da EmpresaDaVita Inc
Data de listagemOct 31, 1995
Fundado em1994
CEOMr. Javier J. Rodriguez
Número de funcionários76000
Tipo de títulosOrdinary Share
Fim do ano fiscalOct 31
Endereço2000 16th St
CidadeDENVER
Bolsa de valoresNYSE Consolidated
PaísUnited States of America
Código postal80202-5117
Telefone13105362668
Sitehttps://www.davita.com/
Código da empresaDVA
Data de listagemOct 31, 1995
Fundado em1994
Executivos da empresa
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Javier J. Rodriguez
Mr. Javier J. Rodriguez
Chief Executive Officer, Director
Chief Executive Officer, Director
837.84K
-4.28%
Mr. Joel Ackerman
Mr. Joel Ackerman
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
101.00K
+8.83%
Ms. Kathleen Alyce Waters
Ms. Kathleen Alyce Waters
Chief Legal and Public Affairs Officer
Chief Legal and Public Affairs Officer
66.98K
+12.40%
Mr. Charles G. (Chuck) Berg, J.D.
Mr. Charles G. (Chuck) Berg, J.D.
Independent Director
Independent Director
26.68K
+1.33%
Ms. Pamela M. Arway
Ms. Pamela M. Arway
Independent Chair of the Board
Independent Chair of the Board
25.23K
+1.40%
Mr. David P. Maughan
Mr. David P. Maughan
Chief Operating Officer - Davita Kidney Care
Chief Operating Officer - Davita Kidney Care
20.58K
-84.60%
Mr. James O. Hearty
Mr. James O. Hearty
Chief Compliance Officer
Chief Compliance Officer
16.63K
+38.27%
Mr. Christopher Michael (Chris) Berry
Mr. Christopher Michael (Chris) Berry
Chief Accounting Officer
Chief Accounting Officer
15.96K
+31.62%
Ms. Phyllis R. Yale
Ms. Phyllis R. Yale
Independent Director
Independent Director
12.85K
+2.79%
Ms. Barbara J. Desoer
Ms. Barbara J. Desoer
Independent Director
Independent Director
12.31K
-27.55%
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Javier J. Rodriguez
Mr. Javier J. Rodriguez
Chief Executive Officer, Director
Chief Executive Officer, Director
837.84K
-4.28%
Mr. Joel Ackerman
Mr. Joel Ackerman
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
101.00K
+8.83%
Ms. Kathleen Alyce Waters
Ms. Kathleen Alyce Waters
Chief Legal and Public Affairs Officer
Chief Legal and Public Affairs Officer
66.98K
+12.40%
Mr. Charles G. (Chuck) Berg, J.D.
Mr. Charles G. (Chuck) Berg, J.D.
Independent Director
Independent Director
26.68K
+1.33%
Ms. Pamela M. Arway
Ms. Pamela M. Arway
Independent Chair of the Board
Independent Chair of the Board
25.23K
+1.40%
Mr. David P. Maughan
Mr. David P. Maughan
Chief Operating Officer - Davita Kidney Care
Chief Operating Officer - Davita Kidney Care
20.58K
-84.60%
Detalhamento da receita
Moeda: USDTempo de atualização: dom, 6 de abr
Moeda: USDTempo de atualização: dom, 6 de abr
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Por EmpresaUSD
Nome
Receita
Proporção
Patient service - Medicare and Medicare Advantage
6.37B
49.74%
Patient service - Commercial
4.03B
31.46%
Patient service - Other government
1.06B
8.28%
Patient service - Medicaid and Managed Medicaid
863.95M
6.74%
Other - Medicare and Medicare Advantage
463.73M
3.62%
Other
19.70M
0.15%
Sem dados
Por Empresa
Por Região
Por EmpresaUSD
Nome
Receita
Proporção
Patient service - Medicare and Medicare Advantage
6.37B
49.74%
Patient service - Commercial
4.03B
31.46%
Patient service - Other government
1.06B
8.28%
Patient service - Medicaid and Managed Medicaid
863.95M
6.74%
Other - Medicare and Medicare Advantage
463.73M
3.62%
Other
19.70M
0.15%
Acionista
Tempo de atualização: sex, 21 de fev
Tempo de atualização: sex, 21 de fev
Estatísticas dos acionistas
Tipo
Estatísticas dos acionistas
Acionista
Proporção
Berkshire Hathaway Inc.
45.72%
The Vanguard Group, Inc.
6.76%
BlackRock Institutional Trust Company, N.A.
3.80%
State Street Global Advisors (US)
3.05%
Weschler (R Ted)
2.84%
Other
37.84%
Estatísticas dos acionistas
Acionista
Proporção
Berkshire Hathaway Inc.
45.72%
The Vanguard Group, Inc.
6.76%
BlackRock Institutional Trust Company, N.A.
3.80%
State Street Global Advisors (US)
3.05%
Weschler (R Ted)
2.84%
Other
37.84%
Tipo
Acionista
Proporção
Holding Company
45.73%
Investment Advisor
22.27%
Investment Advisor/Hedge Fund
21.39%
Individual Investor
4.65%
Hedge Fund
2.78%
Pension Fund
1.91%
Research Firm
1.63%
Bank and Trust
1.09%
Sovereign Wealth Fund
0.11%
Participação acionária institucional
Tempo de atualização: seg, 20 de jan
Tempo de atualização: seg, 20 de jan
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q1
1238
78.42M
98.02%
-4.90M
2024Q4
1260
79.70M
99.28%
-3.76M
2024Q3
1214
80.97M
98.10%
-3.96M
2024Q2
1180
82.28M
96.62%
-4.32M
2024Q1
1166
84.15M
95.98%
-4.07M
2023Q4
1163
84.91M
95.56%
-3.04M
2023Q3
1159
85.40M
93.52%
-3.20M
2023Q2
1164
84.27M
92.30%
-4.64M
2023Q1
1168
84.01M
92.60%
-5.13M
2022Q4
1198
83.55M
92.31%
-8.33M
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
Berkshire Hathaway Inc.
35.14M
43.93%
-953.09K
-2.64%
Feb 19, 2025
The Vanguard Group, Inc.
5.19M
6.49%
-167.41K
-3.12%
Dec 31, 2024
BlackRock Institutional Trust Company, N.A.
2.92M
3.65%
-212.41K
-6.79%
Dec 31, 2024
State Street Global Advisors (US)
2.34M
2.93%
-68.93K
-2.86%
Dec 31, 2024
Weschler (R Ted)
2.18M
2.73%
--
--
Aug 06, 2024
Invesco Capital Management LLC
1.24M
1.54%
+285.57K
+30.05%
Dec 31, 2024
Geode Capital Management, L.L.C.
1.15M
1.44%
-14.40K
-1.24%
Dec 31, 2024
LSV Asset Management
1.03M
1.29%
-25.40K
-2.41%
Dec 31, 2024
Dimensional Fund Advisors, L.P.
902.42K
1.13%
-76.86K
-7.85%
Dec 31, 2024
Rodriguez (Javier J)
894.08K
1.12%
+18.82K
+2.15%
Mar 15, 2025
Ver Mais
ETFs Relacionados
Tempo de atualização: dom, 6 de abr
Tempo de atualização: dom, 6 de abr
Nome
Proporção
Invesco Dorsey Wright Healthcare Momentum ETF
3.43%
Strategas Global Policy Opportunities ETF
2.15%
SPDR S&P Health Care Services ETF
2.14%
Aztlan Global Stock Selection DM SMID ETF
1.72%
First Trust Health Care Alphadex Fund
1.71%
Invesco S&P 500 Equal Weight Health Care ETF
1.51%
Pacer US Cash Cows Growth ETF
1.4%
LG QRAFT AI-Powered US Large Cap Core ETF
1.3%
LeaderShares AlphaFactor US Core ETF
1.26%
Global X Aging Population ETF
1.1%
Ver Mais
Invesco Dorsey Wright Healthcare Momentum ETF
Proporção3.43%
Strategas Global Policy Opportunities ETF
Proporção2.15%
SPDR S&P Health Care Services ETF
Proporção2.14%
Aztlan Global Stock Selection DM SMID ETF
Proporção1.72%
First Trust Health Care Alphadex Fund
Proporção1.71%
Invesco S&P 500 Equal Weight Health Care ETF
Proporção1.51%
Pacer US Cash Cows Growth ETF
Proporção1.4%
LG QRAFT AI-Powered US Large Cap Core ETF
Proporção1.3%
LeaderShares AlphaFactor US Core ETF
Proporção1.26%
Global X Aging Population ETF
Proporção1.1%
Dividendo
Um total de
0.00
USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados
Desdobramento de ações
Data
Tipo
Proporção
Sem dados
Data
Tipo
Proporção
Sem dados